Predicting Recurrence and Progession of Non Muscle Invasive Urothelial Cell Carcinoma of Bladder by Clinical and Pathological Prognostic Factors.
- Author:
Se Young CHOI
1
;
In Ho CHANG
Author Information
1. Department of Urology, College of Medicine, Chung-Ang University, Seoul, Korea. caucih@cau.ac.kr
- Publication Type:Original Article
- Keywords:
Urinary bladder neoplasms;
Risk factors;
Prognosis;
Scoring method
- MeSH:
Drug Therapy;
Humans;
Immunotherapy;
Mycobacterium bovis;
Prognosis;
Recurrence*;
Research Design;
Risk Factors;
Urinary Bladder Neoplasms;
Urinary Bladder*
- From:Korean Journal of Urological Oncology
2015;13(1):1-10
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
About 80% of Bladder cancer is non muscle invasive bladder cancer (NMIBC). Despite of appropriate therapy, a lot of NMIBC recur as a superficial tumor or progress to muscle invasive disease. Several studies about prognostic factors of recurrence and progression have reported a single risk factor variously according to each study. These efforts were developed to predict the risk by scoring system and large-scale studies had been conducted. These studies had limitations that their patients did not receive BCG (bacillus Calmette-Guerin) immunotherapy, immediate intravesical chemotherapy, second-look TUR (transurethral resection) in high-risk group. Through studies to date, patients with NMIBC have showed heterogenous prognosis and a more sophisticated scoring system can give personalized treatment and exact prediction.
